[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Early Diagnosis Kit For Alzheimer's Disease Market Growth 2024-2030

May 2024 | 109 pages | ID: G0DB72D2F5C5EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects the brain, leading to cognitive decline and memory loss. It is the most common cause of dementia, a syndrome characterized by a decline in cognitive function that interferes with daily life. Alzheimer's disease is named after Dr. Alois Alzheimer, who first identified the condition in 1906. Currently, there is not significant leading product on the market, and the competition landscape for AD diagnostic reagents is relatively good. In the future, with the approval of more accurate mass spectrometry and other kits, the application of combined detection methods, and the approval of more AD treatment drugs, the AD diagnostic industry has huge development potential, and the market space may further expand. The cerebrospinal fluid (CSF) biomarkers, that were first developed by Fujirebio more than 25 years ago, have evolved over time from research biomarkers into specialized diagnostic testing tools, and from manual usage by early adopters to a widespread implementation in fully automated routine testing today. Diagnosis for Alzheimer's disease using CSF samples allows the detection of four proteins: two forms of amyloid (A?1-42 and A?1-40) proteins and two forms of Tau (Total Tau and phospho-Tau) proteins. If a patient has Alzheimer's disease, then these proteins will be present in abnormally low (A?1-42 and A?1-42/A?1-40 ratio) and high (Total Tau and phospho-Tau) levels. The A?1-42 levels and the A?1-42/A?1-40 ratio will even be low long before the symptoms of the disease start to show. In the clinical community today, there are high hopes for the use of blood-based testing for even simpler and potentially more widespread testing for Alzheimer's disease in clinical routine.

The global Early Diagnosis Kit For Alzheimer's Disease market size is projected to grow from US$ 122 million in 2024 to US$ 200 million in 2030; it is expected to grow at a CAGR of 8.6% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Early Diagnosis Kit For Alzheimer's Disease Industry Forecast” looks at past sales and reviews total world Early Diagnosis Kit For Alzheimer's Disease sales in 2023, providing a comprehensive analysis by region and market sector of projected Early Diagnosis Kit For Alzheimer's Disease sales for 2024 through 2030. With Early Diagnosis Kit For Alzheimer's Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Early Diagnosis Kit For Alzheimer's Disease industry.

This Insight Report provides a comprehensive analysis of the global Early Diagnosis Kit For Alzheimer's Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Early Diagnosis Kit For Alzheimer's Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Early Diagnosis Kit For Alzheimer's Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Early Diagnosis Kit For Alzheimer's Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Early Diagnosis Kit For Alzheimer's Disease.

Global 3 key players of Carbonized Rice Husk are Roche Diagnostics, Fujirebio and Quanterix, with about 52% market shares. Asia-Pacific is the largest market, which has a share about 38%, followed by Europe and North America, with share 29% and 27%, separately. In terms of product type, CSF is the largest segment, occupied for a share of 59%. And in terms of application, medical is the largest, with a share about 75 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Early Diagnosis Kit For Alzheimer's Disease market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Blood
  • CSF
  • Others
Segmentation by Application:
  • Medical
  • Research
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Fujirebio
  • Quanterix
  • Roche Diagnostics
  • Revvity
  • People Bio
  • Easund Bio-tech and Pharmakea
  • MagQu
  • Solgent
  • Sysmex
  • Fujifilm
  • Immuno-Biological Laboratories
  • Shenzhen Anqun Bioengineering
  • Amoneta Diagnostics
Key Questions Addressed in this Report

What is the 10-year outlook for the global Early Diagnosis Kit For Alzheimer's Disease market?

What factors are driving Early Diagnosis Kit For Alzheimer's Disease market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Early Diagnosis Kit For Alzheimer's Disease market opportunities vary by end market size?

How does Early Diagnosis Kit For Alzheimer's Disease break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Early Diagnosis Kit For Alzheimer's Disease Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Early Diagnosis Kit For Alzheimer's Disease by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Early Diagnosis Kit For Alzheimer's Disease by Country/Region, 2019, 2023 & 2030
2.2 Early Diagnosis Kit For Alzheimer's Disease Segment by Type
  2.2.1 Blood
  2.2.2 CSF
  2.2.3 Others
2.3 Early Diagnosis Kit For Alzheimer's Disease Sales by Type
  2.3.1 Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Type (2019-2024)
  2.3.2 Global Early Diagnosis Kit For Alzheimer's Disease Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Early Diagnosis Kit For Alzheimer's Disease Sale Price by Type (2019-2024)
2.4 Early Diagnosis Kit For Alzheimer's Disease Segment by Application
  2.4.1 Medical
  2.4.2 Research
2.5 Early Diagnosis Kit For Alzheimer's Disease Sales by Application
  2.5.1 Global Early Diagnosis Kit For Alzheimer's Disease Sale Market Share by Application (2019-2024)
  2.5.2 Global Early Diagnosis Kit For Alzheimer's Disease Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Early Diagnosis Kit For Alzheimer's Disease Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Early Diagnosis Kit For Alzheimer's Disease Breakdown Data by Company
  3.1.1 Global Early Diagnosis Kit For Alzheimer's Disease Annual Sales by Company (2019-2024)
  3.1.2 Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Company (2019-2024)
3.2 Global Early Diagnosis Kit For Alzheimer's Disease Annual Revenue by Company (2019-2024)
  3.2.1 Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Company (2019-2024)
  3.2.2 Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Company (2019-2024)
3.3 Global Early Diagnosis Kit For Alzheimer's Disease Sale Price by Company
3.4 Key Manufacturers Early Diagnosis Kit For Alzheimer's Disease Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Early Diagnosis Kit For Alzheimer's Disease Product Location Distribution
  3.4.2 Players Early Diagnosis Kit For Alzheimer's Disease Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR EARLY DIAGNOSIS KIT FOR ALZHEIMER'S DISEASE BY GEOGRAPHIC REGION

4.1 World Historic Early Diagnosis Kit For Alzheimer's Disease Market Size by Geographic Region (2019-2024)
  4.1.1 Global Early Diagnosis Kit For Alzheimer's Disease Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Early Diagnosis Kit For Alzheimer's Disease Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Early Diagnosis Kit For Alzheimer's Disease Market Size by Country/Region (2019-2024)
  4.2.1 Global Early Diagnosis Kit For Alzheimer's Disease Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Early Diagnosis Kit For Alzheimer's Disease Annual Revenue by Country/Region (2019-2024)
4.3 Americas Early Diagnosis Kit For Alzheimer's Disease Sales Growth
4.4 APAC Early Diagnosis Kit For Alzheimer's Disease Sales Growth
4.5 Europe Early Diagnosis Kit For Alzheimer's Disease Sales Growth
4.6 Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales Growth

5 AMERICAS

5.1 Americas Early Diagnosis Kit For Alzheimer's Disease Sales by Country
  5.1.1 Americas Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2019-2024)
  5.1.2 Americas Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2019-2024)
5.2 Americas Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2019-2024)
5.3 Americas Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Early Diagnosis Kit For Alzheimer's Disease Sales by Region
  6.1.1 APAC Early Diagnosis Kit For Alzheimer's Disease Sales by Region (2019-2024)
  6.1.2 APAC Early Diagnosis Kit For Alzheimer's Disease Revenue by Region (2019-2024)
6.2 APAC Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2019-2024)
6.3 APAC Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Early Diagnosis Kit For Alzheimer's Disease by Country
  7.1.1 Europe Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2019-2024)
  7.1.2 Europe Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2019-2024)
7.2 Europe Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2019-2024)
7.3 Europe Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease by Country
  8.1.1 Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2019-2024)
8.2 Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2019-2024)
8.3 Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Early Diagnosis Kit For Alzheimer's Disease
10.3 Manufacturing Process Analysis of Early Diagnosis Kit For Alzheimer's Disease
10.4 Industry Chain Structure of Early Diagnosis Kit For Alzheimer's Disease

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Early Diagnosis Kit For Alzheimer's Disease Distributors
11.3 Early Diagnosis Kit For Alzheimer's Disease Customer

12 WORLD FORECAST REVIEW FOR EARLY DIAGNOSIS KIT FOR ALZHEIMER'S DISEASE BY GEOGRAPHIC REGION

12.1 Global Early Diagnosis Kit For Alzheimer's Disease Market Size Forecast by Region
  12.1.1 Global Early Diagnosis Kit For Alzheimer's Disease Forecast by Region (2025-2030)
  12.1.2 Global Early Diagnosis Kit For Alzheimer's Disease Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Early Diagnosis Kit For Alzheimer's Disease Forecast by Type (2025-2030)
12.7 Global Early Diagnosis Kit For Alzheimer's Disease Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Fujirebio
  13.1.1 Fujirebio Company Information
  13.1.2 Fujirebio Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.1.3 Fujirebio Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Fujirebio Main Business Overview
  13.1.5 Fujirebio Latest Developments
13.2 Quanterix
  13.2.1 Quanterix Company Information
  13.2.2 Quanterix Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.2.3 Quanterix Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Quanterix Main Business Overview
  13.2.5 Quanterix Latest Developments
13.3 Roche Diagnostics
  13.3.1 Roche Diagnostics Company Information
  13.3.2 Roche Diagnostics Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.3.3 Roche Diagnostics Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Roche Diagnostics Main Business Overview
  13.3.5 Roche Diagnostics Latest Developments
13.4 Revvity
  13.4.1 Revvity Company Information
  13.4.2 Revvity Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.4.3 Revvity Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Revvity Main Business Overview
  13.4.5 Revvity Latest Developments
13.5 People Bio
  13.5.1 People Bio Company Information
  13.5.2 People Bio Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.5.3 People Bio Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 People Bio Main Business Overview
  13.5.5 People Bio Latest Developments
13.6 Easund Bio-tech and Pharmakea
  13.6.1 Easund Bio-tech and Pharmakea Company Information
  13.6.2 Easund Bio-tech and Pharmakea Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.6.3 Easund Bio-tech and Pharmakea Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Easund Bio-tech and Pharmakea Main Business Overview
  13.6.5 Easund Bio-tech and Pharmakea Latest Developments
13.7 MagQu
  13.7.1 MagQu Company Information
  13.7.2 MagQu Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.7.3 MagQu Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 MagQu Main Business Overview
  13.7.5 MagQu Latest Developments
13.8 Solgent
  13.8.1 Solgent Company Information
  13.8.2 Solgent Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.8.3 Solgent Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Solgent Main Business Overview
  13.8.5 Solgent Latest Developments
13.9 Sysmex
  13.9.1 Sysmex Company Information
  13.9.2 Sysmex Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.9.3 Sysmex Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Sysmex Main Business Overview
  13.9.5 Sysmex Latest Developments
13.10 Fujifilm
  13.10.1 Fujifilm Company Information
  13.10.2 Fujifilm Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.10.3 Fujifilm Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Fujifilm Main Business Overview
  13.10.5 Fujifilm Latest Developments
13.11 Immuno-Biological Laboratories
  13.11.1 Immuno-Biological Laboratories Company Information
  13.11.2 Immuno-Biological Laboratories Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.11.3 Immuno-Biological Laboratories Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Immuno-Biological Laboratories Main Business Overview
  13.11.5 Immuno-Biological Laboratories Latest Developments
13.12 Shenzhen Anqun Bioengineering
  13.12.1 Shenzhen Anqun Bioengineering Company Information
  13.12.2 Shenzhen Anqun Bioengineering Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.12.3 Shenzhen Anqun Bioengineering Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.12.4 Shenzhen Anqun Bioengineering Main Business Overview
  13.12.5 Shenzhen Anqun Bioengineering Latest Developments
13.13 Amoneta Diagnostics
  13.13.1 Amoneta Diagnostics Company Information
  13.13.2 Amoneta Diagnostics Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
  13.13.3 Amoneta Diagnostics Early Diagnosis Kit For Alzheimer's Disease Sales, Revenue, Price and Gross Margin (2019-2024)
  13.13.4 Amoneta Diagnostics Main Business Overview
  13.13.5 Amoneta Diagnostics Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Early Diagnosis Kit For Alzheimer's Disease Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Early Diagnosis Kit For Alzheimer's Disease Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Blood
Table 4. Major Players of CSF
Table 5. Major Players of Others
Table 6. Global Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2019-2024) & (K Units)
Table 7. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Type (2019-2024)
Table 8. Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Type (2019-2024) & ($ million)
Table 9. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Type (2019-2024)
Table 10. Global Early Diagnosis Kit For Alzheimer's Disease Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Early Diagnosis Kit For Alzheimer's Disease Sale by Application (2019-2024) & (K Units)
Table 12. Global Early Diagnosis Kit For Alzheimer's Disease Sale Market Share by Application (2019-2024)
Table 13. Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Application (2019-2024) & ($ million)
Table 14. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Application (2019-2024)
Table 15. Global Early Diagnosis Kit For Alzheimer's Disease Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Early Diagnosis Kit For Alzheimer's Disease Sales by Company (2019-2024) & (K Units)
Table 17. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Company (2019-2024)
Table 18. Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Company (2019-2024)
Table 20. Global Early Diagnosis Kit For Alzheimer's Disease Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Early Diagnosis Kit For Alzheimer's Disease Producing Area Distribution and Sales Area
Table 22. Players Early Diagnosis Kit For Alzheimer's Disease Products Offered
Table 23. Early Diagnosis Kit For Alzheimer's Disease Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Early Diagnosis Kit For Alzheimer's Disease Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share Geographic Region (2019-2024)
Table 28. Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Early Diagnosis Kit For Alzheimer's Disease Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country/Region (2019-2024)
Table 32. Global Early Diagnosis Kit For Alzheimer's Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2019-2024) & (K Units)
Table 35. Americas Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country (2019-2024)
Table 36. Americas Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2019-2024) & (K Units)
Table 38. Americas Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2019-2024) & (K Units)
Table 39. APAC Early Diagnosis Kit For Alzheimer's Disease Sales by Region (2019-2024) & (K Units)
Table 40. APAC Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Region (2019-2024)
Table 41. APAC Early Diagnosis Kit For Alzheimer's Disease Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2019-2024) & (K Units)
Table 43. APAC Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2019-2024) & (K Units)
Table 44. Europe Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2019-2024) & (K Units)
Table 45. Europe Early Diagnosis Kit For Alzheimer's Disease Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2019-2024) & (K Units)
Table 47. Europe Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Early Diagnosis Kit For Alzheimer's Disease
Table 53. Key Market Challenges & Risks of Early Diagnosis Kit For Alzheimer's Disease
Table 54. Key Industry Trends of Early Diagnosis Kit For Alzheimer's Disease
Table 55. Early Diagnosis Kit For Alzheimer's Disease Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Early Diagnosis Kit For Alzheimer's Disease Distributors List
Table 58. Early Diagnosis Kit For Alzheimer's Disease Customer List
Table 59. Global Early Diagnosis Kit For Alzheimer's Disease Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Early Diagnosis Kit For Alzheimer's Disease Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Early Diagnosis Kit For Alzheimer's Disease Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Early Diagnosis Kit For Alzheimer's Disease Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Early Diagnosis Kit For Alzheimer's Disease Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Early Diagnosis Kit For Alzheimer's Disease Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Early Diagnosis Kit For Alzheimer's Disease Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Early Diagnosis Kit For Alzheimer's Disease Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Early Diagnosis Kit For Alzheimer's Disease Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Fujirebio Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 74. Fujirebio Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 75. Fujirebio Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Fujirebio Main Business
Table 77. Fujirebio Latest Developments
Table 78. Quanterix Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 79. Quanterix Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 80. Quanterix Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Quanterix Main Business
Table 82. Quanterix Latest Developments
Table 83. Roche Diagnostics Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 84. Roche Diagnostics Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 85. Roche Diagnostics Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Roche Diagnostics Main Business
Table 87. Roche Diagnostics Latest Developments
Table 88. Revvity Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 89. Revvity Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 90. Revvity Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Revvity Main Business
Table 92. Revvity Latest Developments
Table 93. People Bio Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 94. People Bio Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 95. People Bio Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. People Bio Main Business
Table 97. People Bio Latest Developments
Table 98. Easund Bio-tech and Pharmakea Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 99. Easund Bio-tech and Pharmakea Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 100. Easund Bio-tech and Pharmakea Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Easund Bio-tech and Pharmakea Main Business
Table 102. Easund Bio-tech and Pharmakea Latest Developments
Table 103. MagQu Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 104. MagQu Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 105. MagQu Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. MagQu Main Business
Table 107. MagQu Latest Developments
Table 108. Solgent Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 109. Solgent Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 110. Solgent Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Solgent Main Business
Table 112. Solgent Latest Developments
Table 113. Sysmex Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 114. Sysmex Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 115. Sysmex Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Sysmex Main Business
Table 117. Sysmex Latest Developments
Table 118. Fujifilm Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 119. Fujifilm Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 120. Fujifilm Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Fujifilm Main Business
Table 122. Fujifilm Latest Developments
Table 123. Immuno-Biological Laboratories Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 124. Immuno-Biological Laboratories Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 125. Immuno-Biological Laboratories Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Immuno-Biological Laboratories Main Business
Table 127. Immuno-Biological Laboratories Latest Developments
Table 128. Shenzhen Anqun Bioengineering Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 129. Shenzhen Anqun Bioengineering Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 130. Shenzhen Anqun Bioengineering Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Shenzhen Anqun Bioengineering Main Business
Table 132. Shenzhen Anqun Bioengineering Latest Developments
Table 133. Amoneta Diagnostics Basic Information, Early Diagnosis Kit For Alzheimer's Disease Manufacturing Base, Sales Area and Its Competitors
Table 134. Amoneta Diagnostics Early Diagnosis Kit For Alzheimer's Disease Product Portfolios and Specifications
Table 135. Amoneta Diagnostics Early Diagnosis Kit For Alzheimer's Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Amoneta Diagnostics Main Business
Table 137. Amoneta Diagnostics Latest Developments

LIST OF FIGURES

Figure 1. Picture of Early Diagnosis Kit For Alzheimer's Disease
Figure 2. Early Diagnosis Kit For Alzheimer's Disease Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Early Diagnosis Kit For Alzheimer's Disease Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Early Diagnosis Kit For Alzheimer's Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country/Region (2023)
Figure 10. Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Blood
Figure 12. Product Picture of CSF
Figure 13. Product Picture of Others
Figure 14. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Type in 2023
Figure 15. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Type (2019-2024)
Figure 16. Early Diagnosis Kit For Alzheimer's Disease Consumed in Medical
Figure 17. Global Early Diagnosis Kit For Alzheimer's Disease Market: Medical (2019-2024) & (K Units)
Figure 18. Early Diagnosis Kit For Alzheimer's Disease Consumed in Research
Figure 19. Global Early Diagnosis Kit For Alzheimer's Disease Market: Research (2019-2024) & (K Units)
Figure 20. Global Early Diagnosis Kit For Alzheimer's Disease Sale Market Share by Application (2023)
Figure 21. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Application in 2023
Figure 22. Early Diagnosis Kit For Alzheimer's Disease Sales by Company in 2023 (K Units)
Figure 23. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Company in 2023
Figure 24. Early Diagnosis Kit For Alzheimer's Disease Revenue by Company in 2023 ($ millions)
Figure 25. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Company in 2023
Figure 26. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Early Diagnosis Kit For Alzheimer's Disease Sales 2019-2024 (K Units)
Figure 29. Americas Early Diagnosis Kit For Alzheimer's Disease Revenue 2019-2024 ($ millions)
Figure 30. APAC Early Diagnosis Kit For Alzheimer's Disease Sales 2019-2024 (K Units)
Figure 31. APAC Early Diagnosis Kit For Alzheimer's Disease Revenue 2019-2024 ($ millions)
Figure 32. Europe Early Diagnosis Kit For Alzheimer's Disease Sales 2019-2024 (K Units)
Figure 33. Europe Early Diagnosis Kit For Alzheimer's Disease Revenue 2019-2024 ($ millions)
Figure 34. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Revenue 2019-2024 ($ millions)
Figure 36. Americas Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country in 2023
Figure 37. Americas Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Country (2019-2024)
Figure 38. Americas Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Type (2019-2024)
Figure 39. Americas Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Application (2019-2024)
Figure 40. United States Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 41. Canada Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 42. Mexico Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 43. Brazil Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 44. APAC Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Region in 2023
Figure 45. APAC Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Region (2019-2024)
Figure 46. APAC Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Type (2019-2024)
Figure 47. APAC Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Application (2019-2024)
Figure 48. China Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 49. Japan Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 50. South Korea Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 51. Southeast Asia Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 52. India Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 53. Australia Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 54. China Taiwan Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 55. Europe Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country in 2023
Figure 56. Europe Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share by Country (2019-2024)
Figure 57. Europe Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Type (2019-2024)
Figure 58. Europe Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Application (2019-2024)
Figure 59. Germany Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 60. France Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 61. UK Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 62. Italy Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 63. Russia Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 64. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Country (2019-2024)
Figure 65. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Early Diagnosis Kit For Alzheimer's Disease Sales Market Share by Application (2019-2024)
Figure 67. Egypt Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 68. South Africa Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 69. Israel Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 70. Turkey Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 71. GCC Countries Early Diagnosis Kit For Alzheimer's Disease Revenue Growth 2019-2024 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Early Diagnosis Kit For Alzheimer's Disease in 2023
Figure 73. Manufacturing Process Analysis of Early Diagnosis Kit For Alzheimer's Disease
Figure 74. Industry Chain Structure of Early Diagnosis Kit For Alzheimer's Disease
Figure 75. Channels of Distribution
Figure 76. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Forecast by Region (2025-2030)
Figure 77. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Early Diagnosis Kit For Alzheimer's Disease Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Early Diagnosis Kit For Alzheimer's Disease Revenue Market Share Forecast by Application (2025-2030)


More Publications